• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 3015516266 SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 3015516266 SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT Back to Search Results
Catalog Number 545035500
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Codes Adhesion(s) (1695); Muscular Rigidity (1968); Pain (1994); Synovitis (2094)
Date of Event 01/30/2024
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2018, the patient underwent a primary right knee replacement using attune implants including a patella and smartset bone cement.On (b)(6) 2018, she experienced a new onset of right knee pain after doing some house cleaning.She states there is a lot of clicking and stiffness as well.Physical therapy is ordered.On (b)(6) 2024, the patient has a right knee bone scan revealing suspected loosening of the femoral and tibial components.On (b)(6) 2024, the patient underwent a right knee revision.Intraoperatively there was scar tissue, extensive synovitis, and the tibial component was confirmed to be loose at the implant to cement interface.The femoral component was well fixed.The patient was revised to competitor implants though the patella was left in situ.Doi: (b)(6) 2018 dor: (b)(6) 2024 right knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Depuy orthopaedics is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy orthopaedics has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy orthopaedics or its employees that the report constitutes an admission that the device, depuy orthopaedics, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.G4: dmf# - 13704 trade name gentamicin sulphate.Active ingredient(s) gentamicin sulphate dosage form - powder strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary no device associated with this report was received for examination.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A records evaluation (mre) was not perform as part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET GHV GENTAMICIN 40G
Common Device Name
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY IRELAND - 3015516266
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key21228444
Report Number1818910-2025-01447
Device Sequence Number12837564
Product Code MBB
UDI-Device Identifier10603295174288
UDI-Public(01)10603295174288(17)190930(10)8647289
Combination Product (Y/N)Y
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K081163
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2019
Device Catalogue Number545035500
Device Lot Number8647289
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 01/08/2025
Supplement Date Received by Manufacturer01/30/2025
Initial Report FDA Received Date01/24/2025
Supplement Report FDA Received Date02/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/12/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
Patient SexFemale
-
-